Carlo Bianchini

Learn More
SUMMARY BACKGROUND DATA The epidemiology of venous thromboembolism (VTE) after cancer surgery is based on clinical trials on VTE prophylaxis that used venography to screen deep vein thrombosis (DVT). However, the clinical relevance of asymptomatic venography-detected DVT is unclear, and the population of these clinical trials is not necessarily(More)
BACKGROUND Clinical trials are needed to assess the clinical benefit of antithrombotic prophylaxis in patients with cancer who are receiving chemotherapy, since these patients are at an increased risk of developing a thromboembolism. We did a trial to assess the clinical benefit of the low-molecular-weight heparin nadroparin for the prophylaxis of(More)
Archaeological surveying undoubtedly belongs with the fields of research most elaborated in this domain of study. This is inevitably linked both to the scale of the problems tackled and - in more strictly `physical' terms - to the fact that this operation is closely and indissolubly related to the continuous evolution of the archaeological excavation. The(More)
In recent years a great debate has aroused concerning the deep transformations triggered by the so-called "digital revolution" in all research fields. Architecture has been highly affected by this phenomenon but, while it is commonplace to measure these changes in terms of "science", much less popular are those aspects connected(More)
Cancer patients receiving chemotherapy are at increased risk of thrombosis. Nadroparin has been demonstrated to reduce the incidence of venous and arterial thrombotic events (TEs) by about 50% in cancer outpatients receiving chemotherapy. The aims of this retrospective analysis were to evaluate the thromboembolic risk and the benefit of thromboprophylaxis(More)
The BIM universe will undoubtedly arouse great and diversified interests amongst actors involved in the design/building process but also of scholars dealing with representation disciplines. The BIM systems appear in fact particularly suitable to respond to both needs providing on a single platform analytic tool, visualization interfaces, assessment(More)
Fifteen patients (6 males, 9 females), age range 36–70 years, were enrolled in a randomized, double-blind, placebo-controlled study according to a Latin-square design, with the aim of comparing 24-hour blood pressure profiles after three 15-day treatment periods with placebo, verapamil SR 120 mg (V120 SR) given twice daily (bid), and verapamil SR 240 mg(More)
The objective of this study was to determine the efficacy of palonosetron combined with dexamethasone in prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) in patients receiving multiple-day chemotherapy and the efficacy of a second dose of palonosetron in treating breakthrough emesis. Forty-six patients treated with(More)
  • 1